Maris Tech director discloses option holdings

Maris Tech Ltd. director Weiss Amitay has reported existing option holdings, not new share purchases or sales.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Maris Tech Ltd. director Weiss Amitay has reported existing option holdings, not new share purchases or sales. The filing shows two share option awards over ordinary shares: one covering 10,000 shares at an exercise price of $1.0000 per share, expiring on February 3, 2027, and another covering 15,000 shares at $1.0600 per share, expiring on March 3, 2029. The first grant, made on February 4, 2022, vests in sixteen equal quarterly installments of 6.25% beginning three months after that date. The second grant, made on March 4, 2024 with a vesting commencement date of January 15, 2024, vests 50% after twenty-four months and the remaining 50% in eight quarterly installments of 6.25% each.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Weiss Amitay

Role Director

Type	Security	Shares	Price	Value
holding	Share option (right to buy)	--	--	--
holding	Share option (right to buy)	--	--	--

Holdings After Transaction: Share option (right to buy) — 25,000 contracts (Direct)

Footnotes (2)

F1. The options granted on February 4, 2022. The options vest in sixteen (16) equal quarterly installments of 6.25% each, beginning three months following February 4, 2022.
F2. The options granted on March 4, 2024. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following the vesting commencement date of January 15, 2024; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Maris Tech (MTEK) director Weiss Amitay report on this Form 3?

Weiss Amitay reported existing holdings of share options over Maris Tech ordinary shares. The filing lists two option grants with defined exercise prices, expiration dates, and vesting schedules, but does not show any new market purchases or sales of the underlying shares.

How many Maris Tech (MTEK) shares are covered by Weiss Amitay’s options?

The Form 3 shows options over 10,000 Maris Tech ordinary shares at an exercise price of $1.0000 and options over 15,000 ordinary shares at $1.0600. These grants together represent option rights over a total of 25,000 underlying ordinary shares.

What are the exercise prices and expirations of Weiss Amitay’s Maris Tech options?

One option grant covers 10,000 ordinary shares at $1.0000 per share, expiring on February 3, 2027. The second covers 15,000 ordinary shares at $1.0600 per share, expiring on March 3, 2029, both held directly by Amitay.

How do Weiss Amitay’s Maris Tech (MTEK) options vest over time?

The 2022 grant vests in sixteen equal quarterly installments of 6.25%, starting three months after February 4, 2022. The 2024 grant vests 50% after twenty-four months from January 15, 2024, with the remaining 50% in eight quarterly installments of 6.25% each.

Does this Maris Tech Form 3 show insider buying or selling activity?

No, this Form 3 records existing option holdings for director Weiss Amitay. It lists the size, pricing, vesting, and expiration of two option grants, but does not report open-market purchases or sales of Maris Tech ordinary shares in this disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 04:37 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Weiss Amitay

(Last)

(First)

(Middle)

C/O MARIS-TECH LTD.

2 YITZHAK MODAI STREET ISRAEL

(Street)

REHOVOT

7608804

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Maris Tech Ltd. [ MTEK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share option (right to buy)	⁽¹⁾	02/03/2027	Ordinary shares	10,000	$1	D
Share option (right to buy)	⁽²⁾	03/03/2029	Ordinary shares	15,000	$1.06	D

Explanation of Responses:

1. The options granted on February 4, 2022. The options vest in sixteen (16) equal quarterly installments of 6.25% each, beginning three months following February 4, 2022.

2. The options granted on March 4, 2024. The options vest according to the following schedule: (i) 50% of the options vested twenty-four (24) months following the vesting commencement date of January 15, 2024; and (ii) the remaining 50% vest in eight (8) equal quarterly installments of 6.25% each thereafter.

	/s/ Amitay Weiss	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR